Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature

Antioxidants and Redox Signaling

Volumn 21, Issue 16, 2014, Pages 2231-2245

  Kelkka, Tiina ^a,b,l   Kienhöfer, Deborah ^c   Hoffmann, Markus ^c   Linja, Marjo ^a   Wing, Kajsa ^d   Sareila, Outi ^a,d   Hultqvist, Malin ^e   Laajala, Essi ^f   Chen, Zhi ^f   Vasconcelos, Júlia ^g   Neves, Esmeralda ^g   Guedes, Margarida ^g   Marques, Laura ^g   Krönke, Gerhard ^c   Helminen, Merja ^h   Kainulainen, Leena ⁱ   Olofsson, Peter ^j   Jalkanen, Sirpa ^a   Lahesmaa, Riitta ^f   Souto Carneiro, M Margarida ^k   Holmdahl, Rikard ^a,d   more..

^a UNIVERSITY OF TURKU   (Finland)

^b Turku Doctoral Programme of Biomedical Sciences   (Finland)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Redoxis AB   (Sweden)

^f TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

^g Centro Hospitalar Universitario do Porto   (Portugal)

^h TAMPERE UNIVERSITY HOSPITAL   (Finland)

ⁱ TURKU UNIVERSITY HOSPITAL   (Finland)

^j Redoxis AB   (Sweden)

^k UNIVERSITY OF COIMBRA   (Portugal)

^l Biomedicum Helsinki   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COMPLEMENT COMPONENT C3; FAS ANTIGEN; IMMUNOGLOBULIN G; INTERFERON; LACTOFERRIN; MYELOBLASTIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; STAT1 PROTEIN; ALPHA INTERFERON; BETA INTERFERON; CYBA PROTEIN, HUMAN; CYBB PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA; NEUTROPHIL CYTOSOLIC FACTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHRONIC GRANULOMATOUS DISEASE; DISEASE PREDISPOSITION; GENE EXPRESSION; GRANULOCYTE; HUMAN; KIDNEY DISEASE; MONOCYTE; MOUSE; NONHUMAN; RESPIRATORY BURST; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; ADOLESCENT; ADULT; ANIMAL; CHILD; DISEASE MODEL; FEMALE; GENETICS; GLOMERULUS; IMMUNOLOGY; MALE; METABOLISM; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; COMPLEMENT C3; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; IMMUNOGLOBULIN G; INTERFERON-ALPHA; INTERFERON-BETA; KIDNEY GLOMERULUS; MALE; MEMBRANE GLYCOPROTEINS; MICE; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; YOUNG ADULT;

EID: 84913594061     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5828     Document Type: Article

References (42)

1. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Fischer A, Franco JL, Geha RS, Hammarstrom L, Nonoyama S, Notarangelo LD, Ochs HD, Puck JM, Roifman CM, Seger R, and Tang ML. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2: 54, 2011.
2. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, and Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526-1533, 2003.
3. Badolato R, Notarangelo LD, Plebani A, and Roos D. Development of systemic lupus erythematosus in a young child affected with chronic granulomatous disease following withdrawal of treatment with interferon-gamma. Rheumatology (Oxford) 42: 804-805, 2003.
4. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, and Behrens TW. Interferoninducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100: 2610-2615, 2003.
5. Bekpen C, Hunn JP, Rohde C, Parvanova I, Guethlein L, Dunn DM, Glowalla E, Leptin M, and Howard JC. The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol 6: R92, 2005.
6. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, and Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197: 711-723, 2003.
7. Blanco P, Palucka AK, Gill M, Pascual V, and Banchereau J. Induction of dendritic cell differentiation by IFN-Alpha in systemic lupus erythematosus. Science 294: 1540-1543, 2001.
8. Bleesing JJ, Souto-Carneiro MM, Savage WJ, Brown MR, Martinez C, Yavuz S, Brenner S, Siegel RM, Horwitz ME, Lipsky PE, Malech HL, and Fleisher TA. Patients with chronic granulomatous disease have a reduced peripheral blood memory B cell compartment. J Immunol 176: 7096-7103, 2006.
9. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, and Elledge SJ. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254, 2009.
10. Cale CM, Morton L, and Goldblatt D. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology. Clin Exp Immunol 148: 79-84, 2007.
11. Campbell AM, Kashgarian M, and Shlomchik MJ. NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci Transl Med 4: 157ra141, 2012.
12. Cobeta-Garcia JC, Domingo-Morera JA, Monteagudo-Saez I, and Lopez-Longo FJ. Autosomal chronic granulomatous disease and systemic lupus erythematosus with fatal outcome. Br J Rheumatol 37: 109-111, 1998.
13. Cunninghame Graham DS, Morris DL, Bhangale TR, Criswell LA, Syvanen AC, Ronnblom L, Behrens TW, Graham RR, and Vyse TJ. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet 7: e1002341, 2011.
14. Dai H, Li Z, Zhang Y, Lv P, and Gao XM. Elevated levels of serum antibodies against Saccharomyces cerevisiae mannan in patients with systemic lupus erythematosus. Lupus 18: 1087-1090, 2009.
15. Degrandi D, Konermann C, Beuter-Gunia C, Kresse A, Wurthner J, Kurig S, Beer S, and Pfeffer K. Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J Immunol 179: 7729-7740, 2007.
16. De Ravin SS, Naumann N, Cowen EW, Friend J, Hilligoss D, Marquesen M, Balow JE, Barron KS, Turner ML, Gallin JI, and Malech HL. Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol 122: 1097-1103, 2008.
17. Dianzani U, Funaro A, DiFranco D, Garbarino G, Bragardo M, Redoglia V, Buonfiglio D, De Monte LB, Pileri A, and Malavasi F. Interaction between endothelium and CD4 + CD45RA + lymphocytes. Role of the human CD38 molecule. J Immunol 153: 952-959, 1994.
18. Galibert L, Burdin N, de Saint-Vis B, Garrone P, Van Kooten C, Banchereau J, and Rousset F. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J Exp Med 183: 77-85, 1996.
19. Gomez-Moyano E, Vera-Casano A, Moreno-Perez D, Sanz-Trelles A, and Crespo-Erchiga V. Lupus erythematosuslike lesions by voriconazole in an infant with chronic granulomatous disease. Pediatr Dermatol 27: 105-106, 2010.
20. Hasui M, Hattori K, Taniuchi S, Kohdera U, Nishikawa A, Kinoshita Y, and Kobayashi Y. Decreased CD4 + CD29 + (memory T) cells in patients with chronic granulomatous disease. J Infect Dis 167: 983-985, 1993.
21. Heltzer M, Jawad AF, Rae J, Curnutte JT, and Sullivan KE. Diminished T cell numbers in patients with chronic granulomatous disease. Clin Immunol 105: 273-278, 2002.
22. Holland SM. Chronic granulomatous disease. Clin Rev Allergy Immunol 38: 3-10, 2010.
23. Huang CK, Zhan L, Hannigan MO, Ai Y, and Leto TL. P47(phox)-Deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J-m db/db and db/+ . J Leukoc Biol 67: 210-215, 2000.
24. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, and Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A 101: 12646-12651, 2004.
25. Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, and Shoenfeld Y. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54: 1232-1236, 2005.
26. Jackson SH, Gallin JI, and Holland SM. The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 182: 751-758, 1995.
27. Jacob CO, Eisenstein M, Dinauer MC, Ming W, Liu Q, John S, Quismorio FP, Jr., Reiff A, Myones BL, Kaufman KM, McCurdy D, Harley JB, Silverman E, Kimberly RP, phagocytic NADPH oxidase (NOX2) activation. J Leukoc Biol 93: 427-435, 2013.
28. Satoh M and Reeves WH. Induction of lupus-Associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 180: 2341-2346, 1994.
29. Schaller J. Illness resembling lupus erythematosus in mothers of boys with chronic granulomatous disease. Ann Intern Med 76: 747-750, 1972.
30. Schappi M, Deffert C, Fiette L, Gavazzi G, Herrmann F, Belli D, and Krause KH. Branched fungal beta-glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase-Deficient mice. J Pathol 214: 434-444, 2008.
31. Schmitt CP, Scharer K, Waldherr R, Seger RA, and Debatin KM. Glomerulonephritis associated with chronic granulomatous disease and systemic lupus erythematosus. Nephrol Dial Transplant 10: 891-895, 1995.
32. Segal BH, Davidson BA, Hutson AD, Russo TA, Holm BA, Mullan B, Habitzruther M, Holland SM, and Knight PR, 3rd. Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-Deficient mice. Am J Physiol Lung Cell Mol Physiol 292: L760-L768, 2007.
33. Sellebjerg F, Krakauer M, Hesse D, Ryder LP, Alsing I, Jensen PE, Koch-Henriksen N, Svejgaard A, and Soelberg Sorensen P. Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-Array evaluation. Eur J Neurol 16: 1291-1298, 2009.
34. Sillevis Smitt JH, Bos JD, Weening RS, and Krieg SR. Discoid lupus erythematosus-like skin changes in patients with autosomal recessive chronic granulomatous disease. Arch Dermatol 126: 1656-1658, 1990.
35. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, and Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 105: 4390-4398, 2005.
36. Sironi M, Guerini FR, Agliardi C, Biasin M, Cagliani R, Fumagalli M, Caputo D, Cassinotti A, Ardizzone S, Zanzottera M, Bolognesi E, Riva S, Kanari Y, Miyazawa M, and Clerici M. An evolutionary analysis of RAC2 identifies haplotypes associated with human autoimmune diseases. Mol Biol Evol 28: 3319-3329, 2011.
37. Somasundaram R, Deuring JJ, van der Woude CJ, Peppelenbosch MP, and Fuhler GM. Linking risk conferring mutations in NCF4 to functional consequences in Crohn's disease. Gut 61: 1097; author reply 1097-1098, 2012.
38. Stalder JF, Dreno B, Bureau B, and Hakim J. Discoid lupus erythematosus-like lesions in an autosomal form of chronic granulomatous disease. Br J Dermatol 114: 251-254, 1986.
39. Strate M, Brandrup F, and Wang P. Discoid lupus erythematosus-like skin lesions in a patient with autosomal recessive chronic granulomatous disease. Clin Genet 30: 184-190, 1986.
40. van de Loo FA, Bennink MB, Arntz OJ, Smeets RL, Lubberts E, Joosten LA, van Lent PL, Coenen-De Roo CJ, Cuzzocrea S, Segal BH, Holland SM, and van den Berg WB. Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models. Am J Pathol 163: 1525-1537, 2003.
41. Yamazaki-Nakashimada MA, Ramirez-Vargas N, and De Rubens-Figueroa J. Chronic granulomatous disease associated with atypical Kawasaki disease. Pediatr Cardiol 29: 169-171, 2008.
42. Zupo S, Rugari E, Dono M, Taborelli G, Malavasi F, and Ferrarini M. CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells. Eur J Immunol 24: 1218-1222, 1994.